|Product Name||Orphenadrine Citrate|
|Therap.Cat :||Antiparkinson Agents|
Agents used in the treatment of Parkinson’s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Cytochrome P-450 CYP2B6 Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of Cytochrome P-450 CYP2B6.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the Muscarinic Antagonists.